SM-102 lipid nanoparticle

SM-102 lipid nanoparticle has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 24, 2026: “RNA delivery favored human blood stem cells in mice”.

Intervention

1 paper studies itUpdated

1 new paper in 30 daysSee all 1

  • Animals1

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
Molecular Therapy

RNA delivery favored human blood stem cells in mice

In humanized mice, antibody-free fat particles delivered more messenger RNA to human blood-forming stem and precursor cells than a comparison formulation.In humanized mice, antibody-free fat particles delivered more messenger RNA to human blood-forming stem and precursor cells than a comparison formulation.

Mouse studyInterventions